NOV INC (NOV) Stock Fundamental Analysis

USA New York Stock Exchange NYSE:NOV • US62955J1034

19.25 USD
+0.68 (+3.66%)
Last: Feb 11, 2026, 02:14 PM
Fundamental Rating

5

Overall NOV gets a fundamental rating of 5 out of 10. We evaluated NOV against 60 industry peers in the Energy Equipment & Services industry. The financial health of NOV is average, but there are quite some concerns on its profitability. NOV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year NOV was profitable.
  • NOV had a positive operating cash flow in the past year.
  • NOV had positive earnings in 4 of the past 5 years.
  • Of the past 5 years NOV 4 years had a positive operating cash flow.
NOV Yearly Net Income VS EBIT VS OCF VS FCFNOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B

1.2 Ratios

  • NOV has a worse Return On Assets (1.28%) than 61.67% of its industry peers.
  • With a Return On Equity value of 2.29%, NOV is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • NOV has a Return On Invested Capital of 4.34%. This is comparable to the rest of the industry: NOV outperforms 45.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NOV is significantly below the industry average of 13.03%.
Industry RankSector Rank
ROA 1.28%
ROE 2.29%
ROIC 4.34%
ROA(3y)5.22%
ROA(5y)2.92%
ROE(3y)9.45%
ROE(5y)5.28%
ROIC(3y)4.56%
ROIC(5y)N/A
NOV Yearly ROA, ROE, ROICNOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • NOV has a Profit Margin of 1.66%. This is in the lower half of the industry: NOV underperforms 63.33% of its industry peers.
  • NOV's Profit Margin has declined in the last couple of years.
  • NOV's Operating Margin of 7.56% is in line compared to the rest of the industry. NOV outperforms 46.67% of its industry peers.
  • NOV's Operating Margin has improved in the last couple of years.
  • NOV has a worse Gross Margin (21.18%) than 63.33% of its industry peers.
  • NOV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.56%
PM (TTM) 1.66%
GM 21.18%
OM growth 3Y20.92%
OM growth 5YN/A
PM growth 3Y-8.17%
PM growth 5YN/A
GM growth 3Y3.11%
GM growth 5Y23.18%
NOV Yearly Profit, Operating, Gross MarginsNOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

6

2. Health

2.1 Basic Checks

  • NOV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • NOV has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NOV has less shares outstanding
  • The debt/assets ratio for NOV has been reduced compared to a year ago.
NOV Yearly Shares OutstandingNOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
NOV Yearly Total Debt VS Total AssetsNOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • The Debt to FCF ratio of NOV is 1.96, which is an excellent value as it means it would take NOV, only 1.96 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 1.96, NOV is doing good in the industry, outperforming 73.33% of the companies in the same industry.
  • NOV has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
  • NOV has a better Debt to Equity ratio (0.27) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.96
Altman-Z N/A
ROIC/WACC0.54
WACC8%
NOV Yearly LT Debt VS Equity VS FCFNOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • NOV has a Current Ratio of 2.42. This indicates that NOV is financially healthy and has no problem in meeting its short term obligations.
  • NOV has a better Current ratio (2.42) than 75.00% of its industry peers.
  • NOV has a Quick Ratio of 1.67. This is a normal value and indicates that NOV is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of NOV (1.67) is better than 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.67
NOV Yearly Current Assets VS Current LiabilitesNOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

4

3. Growth

3.1 Past

  • The earnings per share for NOV have decreased strongly by -64.72% in the last year.
  • The Earnings Per Share has been growing by 13.62% on average over the past years. This is quite good.
  • The Revenue has decreased by -1.42% in the past year.
  • NOV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.50% yearly.
EPS 1Y (TTM)-64.72%
EPS 3Y1.08%
EPS 5Y13.62%
EPS Q2Q%-105.37%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y6.51%
Revenue growth 5Y7.5%
Sales Q2Q%-1.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.19% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, NOV will show a small growth in Revenue. The Revenue will grow by 1.27% on average per year.
EPS Next Y101.39%
EPS Next 2Y54.2%
EPS Next 3Y38.99%
EPS Next 5Y21.19%
Revenue Next Year-0.63%
Revenue Next 2Y1.39%
Revenue Next 3Y2.11%
Revenue Next 5Y1.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NOV Yearly Revenue VS EstimatesNOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
NOV Yearly EPS VS EstimatesNOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

  • NOV is valuated quite expensively with a Price/Earnings ratio of 33.77.
  • The rest of the industry has a similar Price/Earnings ratio as NOV.
  • NOV's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.03.
  • Based on the Price/Forward Earnings ratio of 16.83, the valuation of NOV can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NOV indicates a somewhat cheap valuation: NOV is cheaper than 80.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of NOV to the average of the S&P500 Index (27.97), we can say NOV is valued slightly cheaper.
Industry RankSector Rank
PE 33.77
Fwd PE 16.83
NOV Price Earnings VS Forward Price EarningsNOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NOV indicates a somewhat cheap valuation: NOV is cheaper than 65.00% of the companies listed in the same industry.
  • NOV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. NOV is cheaper than 90.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.02
EV/EBITDA 6.83
NOV Per share dataNOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NOV's earnings are expected to grow with 38.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)2.48
EPS Next 2Y54.2%
EPS Next 3Y38.99%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.62%, NOV has a reasonable but not impressive dividend return.
  • NOV's Dividend Yield is a higher than the industry average which is at 1.13.
  • Compared to an average S&P500 Dividend Yield of 1.80, NOV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.62%

5.2 History

  • On average, the dividend of NOV grows each year by 59.65%, which is quite nice.
  • NOV has paid a dividend for at least 10 years, which is a reliable track record.
  • NOV has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)59.65%
Div Incr Years2
Div Non Decr Years5
NOV Yearly Dividends per shareNOV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 131.03% of the earnings are spent on dividend by NOV. This is not a sustainable payout ratio.
  • The dividend of NOV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP131.03%
EPS Next 2Y54.2%
EPS Next 3Y38.99%
NOV Yearly Income VS Free CF VS DividendNOV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2B -4B -6B
NOV Dividend Payout.NOV Dividend Payout, showing the Payout Ratio.NOV Dividend Payout.PayoutRetained Earnings

NOV INC

NYSE:NOV (2/11/2026, 2:14:07 PM)

19.25

+0.68 (+3.66%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners109.49%
Inst Owner Change-2.59%
Ins Owners0.4%
Ins Owner Change-0.65%
Market Cap7.02B
Revenue(TTM)8.74B
Net Income(TTM)145.00M
Analysts71.67
Price Target18.25 (-5.19%)
Short Float %6.24%
Short Ratio5.75
Dividend
Industry RankSector Rank
Dividend Yield 1.62%
Yearly Dividend0.51
Dividend Growth(5Y)59.65%
DP131.03%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-82.67%
Min EPS beat(2)-108.73%
Max EPS beat(2)-56.61%
EPS beat(4)0
Avg EPS beat(4)-48.37%
Min EPS beat(4)-108.73%
Max EPS beat(4)-2.37%
EPS beat(8)3
Avg EPS beat(8)-15.05%
EPS beat(12)5
Avg EPS beat(12)-8.02%
EPS beat(16)8
Avg EPS beat(16)25.57%
Revenue beat(2)2
Avg Revenue beat(2)2.29%
Min Revenue beat(2)0.65%
Max Revenue beat(2)3.93%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-0.85%
Max Revenue beat(4)3.93%
Revenue beat(8)6
Avg Revenue beat(8)0.64%
Revenue beat(12)8
Avg Revenue beat(12)0.71%
Revenue beat(16)12
Avg Revenue beat(16)1.34%
PT rev (1m)6.75%
PT rev (3m)17.56%
EPS NQ rev (1m)-1.88%
EPS NQ rev (3m)0.81%
EPS NY rev (1m)-2.06%
EPS NY rev (3m)-5.22%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.46%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 33.77
Fwd PE 16.83
P/S 0.8
P/FCF 8.02
P/OCF 5.61
P/B 1.11
P/tB 1.64
EV/EBITDA 6.83
EPS(TTM)0.57
EY2.96%
EPS(NY)1.14
Fwd EY5.94%
FCF(TTM)2.4
FCFY12.48%
OCF(TTM)3.43
OCFY17.82%
SpS23.97
BVpS17.33
TBVpS11.75
PEG (NY)0.33
PEG (5Y)2.48
Graham Number14.91
Profitability
Industry RankSector Rank
ROA 1.28%
ROE 2.29%
ROCE 7.44%
ROIC 4.34%
ROICexc 5.26%
ROICexgc 7.28%
OM 7.56%
PM (TTM) 1.66%
GM 21.18%
FCFM 10.02%
ROA(3y)5.22%
ROA(5y)2.92%
ROE(3y)9.45%
ROE(5y)5.28%
ROIC(3y)4.56%
ROIC(5y)N/A
ROICexc(3y)5.27%
ROICexc(5y)N/A
ROICexgc(3y)7.2%
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3Y23.19%
ROICexgc growth 5YN/A
ROICexc growth 3Y24.53%
ROICexc growth 5YN/A
OM growth 3Y20.92%
OM growth 5YN/A
PM growth 3Y-8.17%
PM growth 5YN/A
GM growth 3Y3.11%
GM growth 5Y23.18%
F-Score5
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.96
Debt/EBITDA 1.66
Cap/Depr 105.63%
Cap/Sales 4.29%
Interest Coverage 250
Cash Conversion 123.13%
Profit Quality 604.14%
Current Ratio 2.42
Quick Ratio 1.67
Altman-Z N/A
F-Score5
WACC8%
ROIC/WACC0.54
Cap/Depr(3y)100.56%
Cap/Depr(5y)87.69%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.72%
EPS 3Y1.08%
EPS 5Y13.62%
EPS Q2Q%-105.37%
EPS Next Y101.39%
EPS Next 2Y54.2%
EPS Next 3Y38.99%
EPS Next 5Y21.19%
Revenue 1Y (TTM)-1.42%
Revenue growth 3Y6.51%
Revenue growth 5Y7.5%
Sales Q2Q%-1.34%
Revenue Next Year-0.63%
Revenue Next 2Y1.39%
Revenue Next 3Y2.11%
Revenue Next 5Y1.27%
EBIT growth 1Y-24.54%
EBIT growth 3Y28.79%
EBIT growth 5YN/A
EBIT Next Year62.31%
EBIT Next 3Y23.25%
EBIT Next 5Y13.14%
FCF growth 1Y-8.08%
FCF growth 3YN/A
FCF growth 5Y4.59%
OCF growth 1Y-4.06%
OCF growth 3YN/A
OCF growth 5Y6.2%

NOV INC / NOV FAQ

What is the fundamental rating for NOV stock?

ChartMill assigns a fundamental rating of 5 / 10 to NOV.


Can you provide the valuation status for NOV INC?

ChartMill assigns a valuation rating of 6 / 10 to NOV INC (NOV). This can be considered as Fairly Valued.


What is the profitability of NOV stock?

NOV INC (NOV) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for NOV stock?

The Earnings per Share (EPS) of NOV INC (NOV) is expected to grow by 101.39% in the next year.


Is the dividend of NOV INC sustainable?

The dividend rating of NOV INC (NOV) is 5 / 10 and the dividend payout ratio is 131.03%.